"New investors", you say? LOL. Seriously. There is no reason for anyone not already invested in CYDY to be buying shares now, given CYDY's track record, lack of CEO, and failure to deliver successfully on any trial. Once management releases some good, solid, material news, THEN we will see new investors. We all hope that news is coming any day now.
Right now, however, if I was looking to invest in a new biotech company, I am pretty sure I would not look too closely at CYDY until they get their act together and there is something more to go on than just speculation as to what 6 weeks of silence means when so much was already supposed to have been told to investors about trial results.